Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Brand-name prescription medicine

Neurontin

Generic name: Gabapentin

FDA application holder: Viatris

Official data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the NDC Directory, Drugs@FDA, the official labels and recall reports; pharmacy costs come from the Centers for Medicare & Medicaid Services (CMS). Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or switch any medicine, including a switch between a brand and a generic.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

Quick answers

What is Neurontin?
Neurontin is a brand name of Gabapentin, a prescription medicine. The FDA NDC Directory lists 8 Neurontin products in 6 strengths and forms.
Who makes Neurontin?
Viatris holds the FDA application for Neurontin (NDA020235, approved December 30, 1993). 1 other company (repackagers or distributors) also list Neurontin products.
Is there a generic or store brand of Neurontin?
Yes. The FDA NDC Directory lists 420 other products with the same active ingredients, strength and form as a Neurontin product, 419 of them generic. Ask your pharmacist whether one is right for you.
What do pharmacies pay for Neurontin?
CMS lists a National Average Drug Acquisition Cost (NADAC) for 5 Neurontin strengths and forms (see the table below). That is what pharmacies pay to buy it, not what you pay: your price depends on your insurance and your pharmacy.
Has Neurontin been recalled?
No recall linked to Neurontin products (by their NDC code or label) appears in the FDA enforcement reports we use.

What Neurontin is

Each Neurontin product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.

Gabapentin · prescription medicine

Strength and formProduct namesSame medicine, other namesLabel
gabapentin 100 mg
capsule (oral)
Neurontin 121 products, 54 companies DailyMed
gabapentin 250 mg/5 mL
solution (oral)
Neurontin 15 products, 13 companies DailyMed
gabapentin 300 mg
capsule (oral)
Neurontin 136 products, 56 companies DailyMed
gabapentin 400 mg
capsule (oral)
Neurontin 89 products, 49 companies DailyMed
gabapentin 600 mg
tablet, film coated (oral)
Neurontin 31 products, 22 companies DailyMed
gabapentin 800 mg
tablet, film coated (oral)
Neurontin 28 products, 20 companies DailyMed

Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Gabapentin →

FDA approval

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
FDA applications of Neurontin products (Drugs@FDA)
ApplicationHolderFirst approvedProducts
NDA020235ViatrisDecember 30, 19934
NDA020882ViatrisOctober 9, 19982
NDA021129ViatrisMarch 2, 20002

What pharmacies pay (NADAC)

The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.

This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.

NADAC per unit for Neurontin, by strength and form
Strength and formGeneric or brandPharmacies pay
gabapentin 100 mg
capsule
Brand: Neurontin $2.96 per capsule
Generic of the same strength and form: $0.0219 per capsule
gabapentin 300 mg
capsule
Brand: Neurontin $7.36 per capsule
Generic of the same strength and form: $0.0328 per capsule
gabapentin 400 mg
capsule
Brand: Neurontin $8.87 per capsule
Generic of the same strength and form: $0.0428 per capsule
gabapentin 600 mg
tablet, film coated
Brand: Neurontin $14.11 per tablet
Generic of the same strength and form: $0.0639–$1.11 per tablet
gabapentin 800 mg
tablet, film coated
Brand: Neurontin $16.88 per tablet
Generic of the same strength and form: $0.0860 per tablet

NADAC list of November 4, 2026; these prices took effect between January 1, 2026 and October 21, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.

Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →

Companies that list Neurontin

The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Neurontin products.

Recalls

No recall linked to Neurontin products (by their NDC code or label) appears in the FDA enforcement reports.

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  3. Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
  5. NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026

Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.

Report an error → · Information for medicine makers